Publikationen, an denen er mitarbeitet Marco Garranzo (1)

2023

  1. A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines

    Frontiers in Microbiology, Vol. 14